🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 hora
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/09/2011 | 43,26 | 44,26 | 43,15 | 43,92 | +1,43% | 2,57% | 1.072.800 |
| 12/09/2011 | 42,77 | 43,50 | 42,25 | 43,30 | +0,07% | 2,92% | 989.200 |
| 09/09/2011 | 44,16 | 44,27 | 42,67 | 43,27 | -2,87% | 3,62% | 1.217.900 |
| 08/09/2011 | 44,23 | 44,96 | 43,81 | 44,55 | +0,20% | 2,60% | 1.200.500 |
| 07/09/2011 | 43,11 | 44,54 | 42,81 | 44,46 | +3,59% | 4,01% | 2.016.800 |
| 06/09/2011 | 40,95 | 43,11 | 40,68 | 42,92 | +3,15% | 5,93% | 1.544.700 |
| 02/09/2011 | 42,21 | 42,76 | 41,29 | 41,61 | -3,03% | 3,48% | 845.100 |
| 01/09/2011 | 42,96 | 43,15 | 42,27 | 42,91 | -0,56% | 2,05% | 997.700 |
| 31/08/2011 | 43,04 | 43,48 | 42,17 | 43,15 | +1,03% | 3,04% | 1.385.700 |
| 30/08/2011 | 40,50 | 42,97 | 40,50 | 42,71 | +4,78% | 6,10% | 2.628.000 |
| 29/08/2011 | 40,51 | 40,99 | 39,93 | 40,76 | +1,72% | 2,62% | 1.931.500 |
| 26/08/2011 | 39,08 | 40,25 | 39,03 | 40,07 | +1,96% | 3,12% | 3.421.500 |
| 25/08/2011 | 39,82 | 40,37 | 39,25 | 39,30 | -1,53% | 2,81% | 4.286.400 |
| 24/08/2011 | 39,15 | 41,40 | 38,87 | 39,91 | -18,15% | 6,46% | 14.409.000 |
| 23/08/2011 | 47,48 | 48,91 | 47,03 | 48,76 | +3,20% | 3,96% | 1.031.200 |
| 22/08/2011 | 49,77 | 49,99 | 46,95 | 47,25 | -3,12% | 6,11% | 1.294.000 |
| 19/08/2011 | 48,47 | 50,24 | 48,07 | 48,77 | -0,41% | 4,48% | 1.504.900 |
| 18/08/2011 | 50,22 | 50,22 | 48,43 | 48,97 | -3,91% | 3,56% | 1.066.400 |
| 17/08/2011 | 51,45 | 51,98 | 50,60 | 50,96 | -0,76% | 2,68% | 713.300 |
| 16/08/2011 | 51,12 | 51,85 | 50,82 | 51,35 | -0,10% | 2,01% | 1.215.500 |
| 15/08/2011 | 50,97 | 51,57 | 50,67 | 51,40 | +1,18% | 1,77% | 946.100 |
| 12/08/2011 | 51,84 | 51,84 | 49,95 | 50,80 | -1,03% | 3,65% | 1.240.500 |
| 11/08/2011 | 50,60 | 51,68 | 49,72 | 51,33 | +3,09% | 3,87% | 1.453.100 |
| 10/08/2011 | 49,97 | 51,15 | 49,35 | 49,79 | -2,20% | 3,60% | 1.374.200 |
| 09/08/2011 | 49,70 | 50,98 | 48,39 | 50,91 | +3,79% | 5,21% | 1.538.700 |
| 08/08/2011 | 49,66 | 51,10 | 48,07 | 49,05 | -3,39% | 6,10% | 1.920.600 |
| 05/08/2011 | 51,52 | 52,51 | 49,07 | 50,77 | -0,47% | 6,68% | 1.158.100 |
| 04/08/2011 | 54,51 | 54,51 | 50,94 | 51,01 | -7,51% | 6,55% | 2.236.000 |
| 03/08/2011 | 55,56 | 55,59 | 52,70 | 55,15 | -0,40% | 5,20% | 1.140.200 |
| 02/08/2011 | 56,46 | 57,48 | 55,29 | 55,37 | -2,24% | 3,88% | 953.200 |